Scientists from the Dr Petra Joh Research House organise an international conference on resistance in cancer in Canterbury, UK

The emergence of resistance is the main reason for the failure of cancer therapies. For this reason, the Interdisciplinary Laboratory for Paediatric Tumour and Virus Research headed by Prof. Dr. Jindrich Cinatl at the Dr. Petra Joh Research House of the Frankfurt Foundation for Children with Cancer is working to better understand the development of resistance in cancer and to enable better cancer therapies. To this end, the Resistant Cancer Cell Line (RCCL) Collection was developed by Prof Cinatl, which is now managed jointly with Prof. Dr. Martin Michaelis (Dr. Petra Joh Research House and University of Kent, Canterbury, UK).

To promote international scientific exchange and collaborative work towards improved understanding and therapies, Prof Michaelis is one of four organisers and hosts of the third ‘Response and Resistance in Cancer Therapy’ conference, supported by the The British Association for Cancer Research (BACR), which will take place at the University of Kent in Canterbury (UK) from 8 to 10 July. Around 150 scientists from leading institutions around the world will meet to discuss the important topic of resistance in cancer. Further information can be found on the BACR website